Understanding the difference between microdose exposure and full therapeutic dosing helps clarify why low-dose experiences may not match the outcomes reported in trial data
Supplementing with a bioavailable form is often necessary to significantly raise systemic levels
Briefly, a closed testing procedure that operated based on an overall significance level of alpha = 0.05 was allocated to the initial test, which was either a test of non-inferiority for SEM 14 mg compared to active comparators (empagliflozin in PIONEER 2 and sitagliptin in PIONEER 3) or a test of superiority for SEM 14 mg compared to placebo (PIONEER 1, 4, and 8)
For companies chasing global expansion or preparing for partnerships or acquisitions, clean, well-prioritized IP portfolios can make or break a deal
Macie Jepson We talked about long term use of of this drug
For instance, high mutation rates in CREBBP/EP300 may regulate NK cell activating receptor (e.g., NKG2D) expression (119, 120)